liver cancer

Pathological Diagnosis, Staging, and Classification of Liver Cancer

by
Pathological Diagnosis, Staging, and Classification of Liver Cancer

Liver cancer is currently the 4th most common malignant tumor in China and the 2nd leading cause of cancer-related death. Liver cancer mainly includes three different pathological types: hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), and combined hepatocellular carcinoma-cholangiocarcinoma (cHCC-CCA). These types differ significantly in terms of pathogenesis, biological behavior, histopathology, treatment methods, and prognosis, with … Read more

Guidelines for Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

by

Recommended Articles:Collect | “Guidelines for Patients with Primary Liver Cancer by the Chinese Anti-Cancer Association”“Collection of 28 Guidelines for Rational Drug Use in Common Diseases at the Grassroots Level (Download PDF)” “Collection of 82 Guidelines for Diagnosis and Treatment of Common Diseases at the Grassroots Level” Protective Equipment Donning and Doffing Video (National Health Commission … Read more

Guidelines And Consensus | Diagnosis And Treatment Guidelines For Primary Liver Cancer (2022 Edition)

by
Guidelines And Consensus | Diagnosis And Treatment Guidelines For Primary Liver Cancer (2022 Edition)

Click the “Chinese Practical Surgery Journal” above to subscribe! [Cite this article] National Health Commission of the People’s Republic of China. Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition) [J]. Chinese Practical Surgery Journal, 2022, 42(3): 241-273. Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition) National Health … Read more

Summary of Immunohistochemical Markers for Liver Cancer

by
Summary of Immunohistochemical Markers for Liver Cancer

In 2020, over 410,000 new cases of liver cancer were reported in China, with more than 390,000 deaths due to liver cancer, bringing the death toll close to the number of new cases. This means that for every 11 newly diagnosed cancer patients, 1 has liver cancer, and almost 1 in 8 patients who die … Read more

Cholangiocarcinoma: Insights and Clinical Perspectives

by
Cholangiocarcinoma: Insights and Clinical Perspectives

Source: Abdominal Medical Imaging Forum Cholangiocarcinoma Intrahepatic cholangiocarcinoma (ICC) is a type of malignant tumor composed of cells similar to bile ducts. Intrahepatic (or peripheral) cholangiocarcinoma (ICC) originates from any part of the intrahepatic bile duct epithelium, such as the large intrahepatic bile duct (segmental and regional ducts and their small branches), and the intrahepatic … Read more

Diagnosis and Staging of Primary Liver Cancer

by
Diagnosis and Staging of Primary Liver Cancer

Primary liver cancer mainly includes three different pathological types: hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), and combined hepatocellular and cholangiocarcinoma (cHCC-CCA). There are significant differences among these three in terms of pathogenesis, biological behavior, histopathology, treatment methods, and prognosis. HCC accounts for 75%~85%, while ICC accounts for 10%~15%. In this article, “liver cancer” refers only … Read more

Suggestions for Redefining, Classifying, and Naming ICC

by
Suggestions for Redefining, Classifying, and Naming ICC

Author: Chen Minshan, Zhou Zhongguo, Xu Li, Zhang Yaojun, Lin Ximeng Source: Chinese Journal of Digestive Surgery, 2021, 20(12) Abstract Currently, there is controversy regarding the definition, classification, and Chinese naming of ICC (intrahepatic cholangiocarcinoma). It is unclear whether ICC belongs to liver cancer or bile duct cancer, and the terms “intrahepatic bile duct cancer” … Read more

Comprehensive Review of Current Advances in Intrahepatic Cholangiocarcinoma Treatment

by
Comprehensive Review of Current Advances in Intrahepatic Cholangiocarcinoma Treatment

Intrahepatic cholangiocarcinoma (ICC) is a lethal malignant tumor, with an incidence rate ranking second among primary liver cancers. In the past decade, the incidence of this disease has increased by 140%. ICC accounts for 20% of all liver malignancies, and 3% of all gastrointestinal malignancies. The disease typically develops against a background of chronic inflammation, … Read more